CCOI is trading at $18.06 after one of its worst weeks in recent memory — a 25% collapse driven by a Q1 earnings report that sent the stock down 22% in a single session.
The catalyst was May 4's Q1 2026 results. Revenues disappointed and the company's path to profitability looked no clearer. The stock fell 22% on the day, dragging it to levels last seen years before. A partial bounce of 10% on May 5 recovered only a fraction of the damage. The stock now sits roughly 35% off its March highs near $27, and securities fraud law firms were already circling by Tuesday morning, flagging investor loss-recovery claims.
The positioning picture reflects a name that was already under meaningful short pressure before the print. Short interest ran at 12% of the free float heading into results — a level that is genuinely significant. Shorts added modestly through the week, with SI up around 1.7% over seven days to approximately 5.7 million shares. That is a mild incremental build, not a panic cover or aggressive new attack; short sellers neither stampeded out on the bounce nor doubled down aggressively. Cost to borrow is extremely low at 0.54%, and the borrow market is comfortably loose, with availability well above 1,000% of short interest — meaning there is abundant capacity to add shorts if the thesis deepens. The ORTEX short score sits at 57.5, a moderate read that has been broadly stable across the past two weeks rather than spiking on the news.
Options positioning has shifted sharply after the print. The put/call ratio jumped to 0.13 on May 5, nearly 3.7 standard deviations above its 20-day mean of 0.10 — an extreme reading by the standard of this particular name. The 52-week range for the PCR is 0.10 to 5.81, so the absolute level is still low in historical terms, but the z-score jump signals that options traders moved abruptly toward relative defensiveness in the two sessions following the earnings collapse. This is new money hedging, not a pre-existing bearish bet.
The analyst response has been almost universally negative on price targets, though not on ratings. RBC Capital (May 6), TD Cowen, and UBS all cut targets — to $18, $34, and $17 respectively — while maintaining their existing ratings of Sector Perform, Buy, and Neutral. The one genuine upgrade came from JPMorgan, which moved CCOI to Overweight from Neutral on May 5 while simultaneously trimming its target from $23 to $22. JPM's call is a contrarian stance: the stock printed a Q1 loss, trades near the UBS bear-case target of $17, and carries meaningful leverage, yet JPM sees enough value at current levels to step up in rating. The Street consensus remains Hold, with six Hold ratings against two Outperform calls. The mean price target of around $21.90 sits just 21% above the current price — a modest implied upside by the standards of a stock that has lost a quarter of its value in a week. The EV/EBITDA multiple has expanded modestly to around 10.5x as the equity price has compressed faster than the enterprise value adjusted.
Institutional ownership adds some context. BlackRock and Vanguard hold 14.4% and 11.1% respectively, with both adding modestly in Q1. Several smaller active managers — Park West, Harspring, Newtyn — initiated or built meaningful positions through late 2025 and into Q1. Those decisions were made at prices of $20–$27. CEO David Schaeffer trimmed a small position in early April at levels well above where the stock now trades. The most recent insider trades on record are a cluster of small executive sells in early March at prices around $22–$23, all well above current levels — hardly a prescient signal, but worth noting as context for management's prior read on value.
What to watch next is the May 7 follow-on event flagged in the calendar — described as an additional earnings-related call — plus any further law firm announcements that could weigh on sentiment independently of the fundamental story. The borrow market's continued looseness means the short interest level is not creating squeeze pressure, and whether the JPMorgan upgrade attracts buyers willing to step in front of the securities investigation headline will define whether the bounce extends or fades back toward the UBS floor target.
See the live data behind this article on ORTEX.
Open CCOI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
